In the study of depression, some scholars have demonstrated that the up-regulated expression level of miR-192-5p inhibits the activation of TGF-β1 signaling pathway by binding to Fbln2, thereby improving cognitive impairment and strengthening neurological function in the mouse model of depression (Tang et al., 2019). Here, FBLN2 is linked to depressive symptom measurement.